Leiderdorp, Netherlands

Pieter Sicco Hiemstra

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pieter Sicco Hiemstra: Innovator in Antimicrobial Peptides

Introduction

Pieter Sicco Hiemstra is a notable inventor based in Leiderdorp, Netherlands. He has made significant contributions to the field of antimicrobial research, particularly through his innovative work on peptides derived from ubiquicidine. His research focuses on developing treatments for infections in both humans and animals.

Latest Patents

Hiemstra holds a patent for "Antimicrobial peptides derived from ubiquicidine." This invention pertains to the use of ubiquicidine or modified peptide fragments derived from it for preparing drugs aimed at treating, diagnosing, or preventing infections. The patent details a peptide fragment that includes a continuous series of amino acids from the sequence of ubiquicidine, specifically highlighting the sequence KVHGSLARAGKVRGQTPKVAKQEKKKKKTGRAKRRMQYNRRFVNVVPTFGKKKGPN ANS (SEQ ID NO: 1). The invention also encompasses hybrid molecules that combine cationic peptides with antimicrobial properties and effector molecules.

Career Highlights

Pieter Sicco Hiemstra is affiliated with Rijksuniversiteit Leiden, where he continues to advance his research in antimicrobial peptides. His work has garnered attention for its potential applications in medical treatments, showcasing his commitment to addressing critical health challenges.

Collaborations

Hiemstra has collaborated with esteemed colleagues, including Petrus Hendricus Nibbering and Maria Theodora Van Den Barselaar. These partnerships have contributed to the depth and breadth of his research, enhancing the impact of his innovations.

Conclusion

Pieter Sicco Hiemstra's contributions to the field of antimicrobial peptides represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments that could improve health outcomes for both humans and animals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…